Group 1 - The core viewpoint of the article is that Kanghua Medical (03689.HK) reported a slight decrease in revenue but achieved a profit for the first half of the fiscal year ending June 30, 2025, marking a turnaround from a loss in the previous period [1][2] - For the six months ending June 30, 2025, the company's revenue decreased by 0.3% to RMB 980 million [1] - The profit attributable to the company's owners for the same period was RMB 41.6 million, compared to a loss of RMB 19.5 million for the six months ending June 30, 2024 [1] Group 2 - The earnings per share for the reporting period was RMB 0.125, a significant improvement from a loss per share of RMB 0.058 in the previous period [1] - The board of directors did not recommend the payment of an interim dividend for the six months ending June 30, 2025, consistent with the previous period where no dividend was declared [1] - Kanghua Medical also issued a profit warning, expecting a profit of between RMB 32 million to RMB 33 million for the interim period [2]
康华医疗(03689.HK)中期扭亏为盈至4160万元